Literature DB >> 23467919

Preoperatively determinable factors predictive of diabetes mellitus remission following Roux-en-Y gastric bypass: a review of the literature.

S T Adams1, M Salhab, Z I Hussain, G V Miller, S H Leveson.   

Abstract

It is well established that weight loss in general and bariatric surgery in particular can improve glycaemic control in diabetics. Current NICE guidelines recommend that those patients with type 2 diabetes mellitus and a BMI of 35 kg/m(2) or more should be considered for bariatric surgery in order to optimise their glycaemic control and minimise their risk of long-term complications. The commonest bariatric procedure in the UK is the Roux-en-Y gastric bypass that has been shown to result in long-standing type 2 diabetes resolution in 83 % of patients. Since such surgery carries a small but significant risk of mortality, as well as posing considerable lifestyle implications for the patient, numerous studies have been performed with a view to identifying which patients and which procedures are most likely to result in these desired benefits. This paper summarises the existing literature on this topic.

Entities:  

Mesh:

Year:  2013        PMID: 23467919     DOI: 10.1007/s00592-013-0453-2

Source DB:  PubMed          Journal:  Acta Diabetol        ISSN: 0940-5429            Impact factor:   4.280


  6 in total

1.  Preoperative β-cell function in patients with type 2 diabetes is important for the outcome of Roux-en-Y gastric bypass surgery.

Authors:  Michael Taulo Lund; Merethe Hansen; Stinna Skaaby; Sina Dalby; Mikael Støckel; Andrea Karen Floyd; Karsten Bech; Jørn Wulff Helge; Jens Juul Holst; Flemming Dela
Journal:  J Physiol       Date:  2015-06-17       Impact factor: 5.182

2.  Type 2 Diabetes Remission After Gastric Bypass: What Is the Best Prediction Tool for Clinicians?

Authors:  Aurélie Cotillard; Christine Poitou; Guillemette Duchâteau-Nguyen; Judith Aron-Wisnewsky; Jean-Luc Bouillot; Thomas Schindler; Karine Clément
Journal:  Obes Surg       Date:  2015-07       Impact factor: 4.129

3.  Surgical treatment of type 2 diabetes in subjects with mild obesity: mechanisms underlying metabolic improvements.

Authors:  A C Fellici; G Lambert; M M O Lima; J C Pareja; S Rodovalho; E A Chaim; Bruno Geloneze
Journal:  Obes Surg       Date:  2015-01       Impact factor: 4.129

4.  Preoperative Prediction of Type 2 Diabetes Remission After Gastric Bypass Surgery: a Comparison of DiaRem Scores and ABCD Scores.

Authors:  Wei-Jei Lee; Keong Chong; Shu-Chun Chen; James Zachariah; Kong-Han Ser; Yi-Chih Lee; Jung-Chien Chen
Journal:  Obes Surg       Date:  2016-10       Impact factor: 4.129

5.  Validating Risk Prediction Models of Diabetes Remission After Sleeve Gastrectomy.

Authors:  Shih-Chiang Shen; Weu Wang; Ka-Wai Tam; Hsin-An Chen; Yen-Kuang Lin; Shih-Yun Wang; Ming-Te Huang; Yen-Hao Su
Journal:  Obes Surg       Date:  2019-01       Impact factor: 4.129

Review 6.  Recent advancements in bariatric/metabolic surgery.

Authors:  Wei-Jei Lee; Owaid Almalki
Journal:  Ann Gastroenterol Surg       Date:  2017-09-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.